Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families

Author:

Cianci VittoriaORCID,Pascarella AngeloORCID,Manzo LuciaORCID,Gasparini SaraORCID,Marsico OresteORCID,Mammì Anna,Rao Carmelo Massimiliano,Franzutti Claudio,Aguglia UmbertoORCID,Ferlazzo EdoardoORCID

Abstract

Abstract Background The GLA c.337T > C (p.Phe113Leu) is a known pathogenic variant associated to late-onset Fabry disease phenotype with predominant cardiac manifestations. A founder effect was demonstrated in a large cohort in the Portuguese region of Guimarães. Herein we report an in-depth phenotype description of a cluster of five Southern Italy families. Methods Family pedigrees of five index males with the p.Phe113Leu variant were obtained and all at-risk relatives underwent biochemical and genetical screening test. Carriers of GLA p.Phe113Leu variant underwent subsequent multidisciplinary clinical and instrumental evaluation. Results Thirty-one (16 M, 15 F) individuals with p.Phe113Leu pathogenic variant were identified. Sixteen out of 31 patients (51.6%) had cardiac manifestations. Notably, myocardial fibrosis was found in 7/8 patients, of whom 2 were under 40 years. Stroke occurred in 4 patients. White matter lesions were detected in 12/19 patients and occurred in 2/10 of subjects under 40 years. Seven females complained of acroparesthesias. Renal involvement occurred in 10 patients. Angiokeratomas were evident in 9 subjects. Eyes, ear, gastrointestinal and pulmonary involvement occurred in the minority of subjects. Conclusion This study demonstrates that a cluster of subjects with p.Phe113Leu pathogenic variant is also present in Southern Italy. Disease manifestations are frequent in both sexes and may occur early in life. Cardiac involvement represents the core manifestation, but neurological and renal involvement is also frequent, suggesting that extra-cardiac complications deserve clinical attention.

Funder

Università degli studi “Magna Graecia” di Catanzaro

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Biochemistry

Reference46 articles.

1. Alharbi FJ, Baig S, Auray-Blais C, Boutin M, Ward DG, Wheeldon N, Steed R, Dawson C, Hughes D, Geberhiwot T (2018) Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) fabry disease. J Inherit Metab Dis 41:239–247. https://doi.org/10.1007/s10545-017-0127-2

2. Aquaro GD, De Gori C, Faggioni L, Parisella ML, Aringhieri G, Cioni D, Lencioni R, Neri E (2022) Cardiac magnetic resonance in Fabry Disease: morphological, functional, and tissue features. Diagnostics (Basel) 12:2652. https://doi.org/10.3390/diagnostics12112652

3. Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, Elliott PM, Linthorst GE, Wijburg FA, Biegstraaten M, Hollak CE (2017) Characterization of classical and nonclassical fabry disease: a Multicenter Study. J Am Soc Nephrol 28:1631–1641. https://doi.org/10.1681/ASN.2016090964

4. Azevedo O, Gago MF, Miltenberger-Miltenyi G, Robles AR, Costa MA, Pereira O, Vide AT, Castelo Branco G, Simões S, Guimarães MJ, Salgado A, Sousa N, Cunha D (2020a) Natural history of the late-onset phenotype of fabry disease due to the p.F113L mutation. Mol Genet Metab Rep 22:100565. 10.1016/j.ymgmr.2020a.100565

5. Azevedo O, Gal A, Faria R, Gaspar P, Miltenberger-Miltenyi G, Gago MF, Dias F, Martins A, Rodrigues J, Reimão P, Pereira O, Simões S, Lopes E, Guimarães MJ, Sousa N, Cunha D (2020b) Founder effect of fabry disease due to p.F113L mutation: clinical profile of a late-onset phenotype. Mol Genet Metab 129:150–160. 10.1016/j.ymgme.2019.07.012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3